Worried About a Crash in Artificial Intelligence (AI) Stocks? Instantly Diversify Your Portfolio With This Spectacular Vanguard ETF.
Jun 8, 2026 by Selena Maranjian3 Stocks I'm Not Selling No Matter What the Market Does for the Next 20 YearsOne of these has averaged annual gains of 69% over the past decade, and it still looks undervalued.
Jun 8, 2026 by Rick Munarriz3 Stocks That Can Bounce Back This Week After Falling More Than 10% on FridayThree stocks that each tumbled 11% on Friday could bounce back, sooner than you think.
Jun 8, 2026 by Geoffrey SeilerThe Smartest Vanguard ETF to Buy With $500 Right NowThe Vanguard S&P 500 ETF is a great investment.
Jun 8, 2026 by Selena Maranjian3 Stocks I'm Not Selling No Matter What the Market Does for the Next 20 YearsOne of these has averaged annual gains of 69% over the past decade, and it still looks undervalued.
Jun 8, 2026 by Sara AppinoClean Energy or Pipeline Infrastructure? ICLN and AMLP Are Betting on Different Energy Futures.Compare sector focus, diversification, and historical performance to see how these two energy ETFs stack up for different investment priorities.
Jun 8, 2026 by Jack DelaneyHow to Buy SpaceX Stock on Its IPO DayAhead of June 12, investors will want to have their SpaceX IPO investing game plan ready.
Jun 8, 2026 by Lawrence Rothman, CFABlackbaud's CFO Sells SharesThis cloud software provider for mission-driven organizations reported a notable insider sale amid a challenging year for its stock.
Jun 8, 2026 by Neil PatelStrategy Stock Is Down 75%: Has Billionaire Michael Saylor's Bitcoin Treasury Experiment Failed?The bears are taking a victory lap, but there's more to the story than the stock's dip.
Jun 8, 2026 by Matt Frankel, CFP5 Quotes From SoFi's CEO Investors Need to HearThese Anthony Noto quotes may change the way you think about SoFi stock.
Jun 8, 2026 by Rick Munarriz3 Stocks That Can Bounce Back This Week After Falling More Than 10% on FridayThree stocks that each tumbled 11% on Friday could bounce back, sooner than you think.
Jun 8, 2026 by Lawrence Rothman, CFAThe One Market That Could Make or Break Tilray StockMost of Tilray's sales come from Canada and the European Union.
Jun 8, 2026 by Neha ChamariaWhy Symbotic Stock Slumped 21% in May And Just Hit a 2026 LowIs something seriously wrong with the automation expert, or is this a market overreaction and an opportunity to buy?
Jun 8, 2026 by Geoffrey SeilerThe Smartest Vanguard ETF to Buy With $500 Right NowThe Vanguard S&P 500 ETF is a great investment.
Jun 8, 2026 by Maurie BackmanI Used to Think Maxing Out a 401(k) Always Made Sense. Here's Why I Was Wrong.While it's good to contribute a lot to a tax-advantaged account, there can be a huge drawback.
Jun 8, 2026 by TMF Breakfast NewsBreakfast News: Can A New 'AI Siri' Boost Apple?Apple's developer conference set to open, markets turn away from chip stocks, and more...
Jun 8, 2026 by Sara Appino2 of the Most Trusted Total Market ETFs Go Head to Head: VTI vs. SPTMExplore how portfolio size and sector weights impact risk and returns for long-term investors seeking broad U.S. equity coverage.
Jun 8, 2026 by Justin PopeCan Medtronic Finally Challenge Intuitive Surgical's Robotic Surgical Systems Dominance?Medtronic wants a bite of the robotics-assisted surgery market, which could swell to over $63 billion over the next decade.
Jun 8, 2026 by Rich SmithNASA Has Big Plans for the Moon. Here Are Some of Them.NASA had big plans for the Moon -- then Blue Origin blew them up. What does this mean for investors now?
Jun 8, 2026 by Sara AppinoFTXG vs. PBJ: Same Pantry, Same Fee, but the 5-Year Returns Tell a Different StoryTheir expense ratios are nearly identical, but portfolio strategies and risk profiles set these food and beverage funds apart for sector-focused investors.
Jun 8, 2026 by Joel O'LearyI Didn't Open a Roth IRA Until 31. Here's What That Delay Really CostOpening a Roth IRA eight years earlier would have left me $280,000 richer today. Here are the current contribution limits and how to start now.
Jun 8, 2026 by Andy GouldNan Fung Group Sells $4.3 Million in Oculis Shares As Lead Drug StumblesOculis advances late-stage topical therapies for diabetic and neuro-ophthalmic eye diseases in the clinical-stage biotech sector.
Jun 8, 2026 by Ryan VanzoMark Your Calendar: SpaceX Could Be a Very Different Stock After June 12Some experts warn against participating in the SpaceX IPO.
Jun 8, 2026 by Keith NoonanWhy Poet Technologies Skyrocketed 72.6% Last Month But Is Sinking in JunePoet stock has been incredibly volatile in 2026, but it's still up 87% year to date.
